Literature DB >> 26724946

Atypical Clinical Presentations of TAZ Mutations: An Underdiagnosed Cause of Growth Retardation?

Charlotte Thiels1,2, Martin Fleger3, Martina Huemer3,4, Richard J Rodenburg5, Frederic M Vaz6, Riekelt H Houtkooper6, Tobias B Haack7,8, Holger Prokisch7,8, René G Feichtinger9, Thomas Lücke1,2, Johannes A Mayr9, Saskia B Wortmann10,11.   

Abstract

Barth syndrome is known as a highly recognizable X-linked disorder typically presenting with the three hallmarks: (left ventricular non-compaction) cardiomyopathy, neutropenia, and 3-methylglutaconic aciduria. Furthermore, growth retardation, mild skeletal myopathy, and specific facial features as well as mitochondrial dysfunction in muscle are frequently seen. Underlying mutations are found in TAZ and lead to defective cardiolipin remodeling.Here, we report atypical clinical manifestations of TAZ mutations in two male patients initially presenting with growth retardation and very mild skeletal myopathy. As other phenotypic hallmarks were missing, Barth syndrome had not been suspected in these patients. One of them has been incidentally diagnosed in the frame of an in-depth cardiolipin research analysis, while the underlying genetic defect was unexpectedly identified in the second one by exome sequencing.
CONCLUSION: These cases underline that TAZ mutations might well be an underdiagnosed cause of skeletal myopathy and growth retardation and do not necessarily manifest with the full clinical picture of Barth syndrome.

Entities:  

Keywords:  3-Methylglutaconic aciduria; Barth syndrome; Failure to thrive; Gowers’ sign; Myopathy

Year:  2016        PMID: 26724946      PMCID: PMC5059176          DOI: 10.1007/8904_2015_525

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  13 in total

1.  Alterations of oxidative phosphorylation complexes in astrocytomas.

Authors:  René Günther Feichtinger; Serge Weis; Johannes Adalbert Mayr; Franz Zimmermann; Reinhard Geilberger; Wolfgang Sperl; Barbara Kofler
Journal:  Glia       Date:  2014-01-20       Impact factor: 7.452

2.  Cardiac and clinical phenotype in Barth syndrome.

Authors:  Carolyn T Spencer; Randall M Bryant; Jane Day; Iris L Gonzalez; Steven D Colan; W Reid Thompson; Julie Berthy; Sharon P Redfearn; Barry J Byrne
Journal:  Pediatrics       Date:  2006-07-17       Impact factor: 7.124

3.  Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening.

Authors:  Tobias B Haack; Matteo Gorza; Katharina Danhauser; Johannes A Mayr; Birgit Haberberger; Thomas Wieland; Laura Kremer; Valentina Strecker; Elisabeth Graf; Yasin Memari; Uwe Ahting; Robert Kopajtich; Saskia B Wortmann; Richard J Rodenburg; Urania Kotzaeridou; Georg F Hoffmann; Wolfgang Sperl; Ilka Wittig; Ekkehard Wilichowski; Gudrun Schottmann; Markus Schuelke; Barbara Plecko; Ulrich Stephani; Tim M Strom; Thomas Meitinger; Holger Prokisch; Peter Freisinger
Journal:  Mol Genet Metab       Date:  2013-12-25       Impact factor: 4.797

4.  The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study.

Authors:  Amy E Roberts; Connie Nixon; Colin G Steward; Kimberly Gauvreau; Melissa Maisenbacher; Matthew Fletcher; Judith Geva; Barry J Byrne; Carolyn T Spencer
Journal:  Am J Med Genet A       Date:  2012-10-08       Impact factor: 2.802

5.  3-Methylglutaconic aciduria--lessons from 50 genes and 977 patients.

Authors:  Saskia B Wortmann; Leo A J Kluijtmans; Richard J Rodenburg; Jörn Oliver Sass; Jessica Nouws; Edwin P van Kaauwen; Tjitske Kleefstra; Lisbeth Tranebjaerg; Maaike C de Vries; Pirjo Isohanni; Katharina Walter; Fowzan S Alkuraya; Izelle Smuts; Carolus J Reinecke; Francois H van der Westhuizen; David Thorburn; Jan A M Smeitink; Eva Morava; Ron A Wevers
Journal:  J Inherit Metab Dis       Date:  2013-01-25       Impact factor: 4.982

6.  Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.

Authors:  Riekelt H Houtkooper; Richard J Rodenburg; Charlotte Thiels; Henk van Lenthe; Femke Stet; Bwee Tien Poll-The; Janet E Stone; Colin G Steward; Ronald J Wanders; Jan Smeitink; Willem Kulik; Frédéric M Vaz
Journal:  Anal Biochem       Date:  2009-01-31       Impact factor: 3.365

7.  X-linked fetal cardiomyopathy caused by a novel mutation in the TAZ gene.

Authors:  April N Brady; Bahig M Shehata; Paul M Fernhoff
Journal:  Prenat Diagn       Date:  2006-05       Impact factor: 3.050

8.  Natural history of Barth syndrome: a national cohort study of 22 patients.

Authors:  Charlotte Rigaud; Anne-Sophie Lebre; Renaud Touraine; Blandine Beaupain; Chris Ottolenghi; Allel Chabli; Helene Ansquer; Hulya Ozsahin; Sylvie Di Filippo; Pascale De Lonlay; Betina Borm; Francois Rivier; Marie-Catherine Vaillant; Michèle Mathieu-Dramard; Alice Goldenberg; Géraldine Viot; Philippe Charron; Marlene Rio; Damien Bonnet; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2013-05-08       Impact factor: 4.123

Review 9.  Barth syndrome.

Authors:  Sarah L N Clarke; Ann Bowron; Iris L Gonzalez; Sarah J Groves; Ruth Newbury-Ecob; Nicol Clayton; Robin P Martin; Beverly Tsai-Goodman; Vanessa Garratt; Michael Ashworth; Valerie M Bowen; Katherine R McCurdy; Michaela K Damin; Carolyn T Spencer; Matthew J Toth; Richard I Kelley; Colin G Steward
Journal:  Orphanet J Rare Dis       Date:  2013-02-12       Impact factor: 4.123

10.  New clinical and molecular insights on Barth syndrome.

Authors:  Lorenzo Ferri; Maria Alice Donati; Silvia Funghini; Sabrina Malvagia; Serena Catarzi; Licia Lugli; Luca Ragni; Enrico Bertini; Frédéric M Vaz; David N Cooper; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2013-02-14       Impact factor: 4.123

View more
  3 in total

1.  Previously Unreported Biallelic Mutation in DNAJC19: Are Sensorineural Hearing Loss and Basal Ganglia Lesions Additional Features of Dilated Cardiomyopathy and Ataxia (DCMA) Syndrome?

Authors:  Sema Kalkan Ucar; Johannes A Mayr; René G Feichtinger; Ebru Canda; Mahmut Çoker; Saskia B Wortmann
Journal:  JIMD Rep       Date:  2016-12-08

Review 2.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

3.  Neutropenia in Barth syndrome: characteristics, risks, and management.

Authors:  Colin G Steward; Sarah J Groves; Carolyn T Taylor; Melissa K Maisenbacher; Birgitta Versluys; Ruth A Newbury-Ecob; Hulya Ozsahin; Michaela K Damin; Valerie M Bowen; Katherine R McCurdy; Michael C Mackey; Audrey A Bolyard; David C Dale
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.